effects [qlco]
tibolone [phsu, strd]
Continuous [idcn]
Combined [qlco]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
medroxyprogesterone acetate [horm, phsu, strd]
Lipoprotein (a) [aapp, bacs]
Menopause [phsf]
Study, Prospective [resa]
Controlled [ftcn]
effects [qlco]
Therapies [topp]
Menopause [phsf]
Factor VII [aapp, bacs, phsu]
haemostatic [ortf]
variables [qlco]
Methods [inpr]
postmenopausal [tmco]
Women [popg]
Assigned [ftcn]
Receive [qlco]
Following [tmco]
Treatments [topp]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
E2 [gngm]
mU/g [qnco]
Combined [qlco]
Continuous [idcn]
Sequential [idcn]
Regimen [topp]
Oral [spco]
medroxyprogesterone acetate [horm, phsu, strd]
mg day [qnco]
days [tmco]
Group A [clas]
N NOS [aapp, imft]
tibolone [phsu, strd]
2 5 [qnco]
mg day [qnco]
Group [idcn]
N NOS [aapp, imft]
placebo [topp]
Group C [clas]
N NOS [aapp, imft]
Women [popg]
COMPLETED [qlco]
treatment [ftcn]
Follow-up examination [fndg]
months [tmco]
E2 [gngm]
Induced [ftcn]
Various [irda]
months [tmco]
Fibrinogen [aapp, bacs, phsu]
Factor VII, Activated [aapp, enzy, phsu]
Factor VII [aapp, bacs, phsu]
Increased [qnco]
fibrinolytic [topp]
Plasminogen [aapp, bacs, phsu]
alpha-2-Antiplasmin [aapp, bacs, phsu]
Increased [qnco]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
Antithrombin III [aapp, phsu]
Variation [qlco]
tibolone [phsu, strd]
Induced [ftcn]
Homogeneous [qlco]
Profile [lbpr]
Fibrinogen [aapp, bacs, phsu]
Decreased [qnco]
Plasminogen [aapp, bacs, phsu]
Increased [qnco]
Lp(a) [aapp, bacs]
Decreased [qnco]
Antithrombin III [aapp, phsu]
Unchanged [fndg]
tibolone [phsu, strd]
therapy [ftcn]
tibolone [phsu, strd]
reduction [npop]
Lp(a) [aapp, bacs]
Enhancement [topp]
Promoting [acty]
Fibrinolysis [phsf]
E2 [gngm]
Regimen [topp]
Copyright [inpr]
basel [hcro]
